Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice
Open Access
- 24 August 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Brain metastases (BM) are frequently detected during the follow-up of patients with malignant tumors, particularly in those with advanced disease. Despite a major progress in systemic anti-cancer treatments, the average overall survival of these patients remains limited (6 months from diagnosis). Also, cognitive decline is regularly reported especially in patients treated with whole brain external beam radiotherapy (WBRT), due to the absorbed radiation dose in healthy brain tissue. New targeted therapies, for an earlier and/or more specific treatment of the tumor and its microenvironment, are needed. Radioimmunotherapy (RIT), a combination of a radionuclide to a specific antibody, appears to be a promising tool. Inflammation, which is involved in multiple steps, including the early phase, of BM development is attractive as a relevant target for RIT. This review will focus on the (1) early biomarkers of inflammation in BM pertinent for RIT, (2) state of the art studies on RIT for BM, and (3) the importance of dosimetry to RIT in BM. These two last points will be addressed in comparison to the conventional EBRT treatment, particularly with respect to the balance between tumor control and healthy tissue complications. Finally, because new diagnostic imaging techniques show a potential for the detection of BM at an early stage of the disease, we focus particularly on this therapeutic window.Keywords
This publication has 40 references indexed in Scilit:
- Functional role of endothelial adhesion molecules in the early stages of brain metastasisNeuro-Oncology, 2013
- Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET StudyCancer Immunology Research, 2013
- Role of the systemic immune system in brain metastasisMolecular and Cellular Neuroscience, 2013
- Role of connexins in metastatic breast cancer and melanoma brain colonizationJournal of Cell Science, 2013
- Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis modelJournal of Neuro-Oncology, 2012
- Molecular MRI enables early and sensitive detection of brain metastasesProceedings of the National Academy of Sciences, 2012
- EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reportingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Radiation Dose–Volume Effects in the BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide TherapyJournal of Nuclear Medicine, 2010
- Real-time imaging reveals the single steps of brain metastasis formationNature Medicine, 2009